版本:
中国

BRIEF-Sangamo Therapeutics enters into amended and restated agreement with Cowen and Company

May 26 Sangamo Therapeutics Inc

* On May 26 co entered into amended and restated at-market offering program sales agreement with Cowen and Company

* Co may issue and sell from time to time up to $75.0 million of common stock, par value $0.01 per share, through Cowen as sales agent

* Amended sales agreement amends and restates in its entirety and supersedes sales agreement dated December 7, 2016 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐